$XBI - Positive DivergenceThe SPDR BioTech ETF $XBI has been an underperforming for a long time. However, there's clues that could be changing. There's a nice positive divergence on the RSI. The down trend line was broken after several failed attempts. The stock is above the 50 day MA for the first time in over a year. Both the 20 SMA and the 50 SMA are curling upwards. RSI is positive. I like this long above the possible resistance area of $96.91.
The tripled levered bull equivalent $LABU looks just as good with even better volume.
I like the ETF long above $96.91. With a target up to the 200 SMA. of about $114.00
Under $96.91 and it's probably best to stay away.
Thanks for checking this out. Good luck to all.